<DOC>
	<DOCNO>NCT02081703</DOCNO>
	<brief_summary>The objective study evaluate safety analgesic efficacy single preoperative intrathecal administration AYX1 Injection two dose/volume level .</brief_summary>
	<brief_title>Study Evaluate Safety/Efficacy Single Pre-Op Dose AYX1 Injection Treat Pain After Knee Replacement Surgery</brief_title>
	<detailed_description />
	<criteria>Scheduled undergo primary unilateral TKA painful osteoarthritis without congenital knee pathology American Society Anesthesiologists Physical Status Classification System â‰¤ 3 Medically stable determine Investigator base prestudy medical history , physical/neurological examination , clinical laboratory test , 12lead electrocardiogram ( ECG ) finding Body Mass Index 1840 kg/m2 Stable medical regimen least 1 month randomization Able read understand study instruction English , willing able comply study procedures More 2 current focal area pain , none great intensity target knee active chronic pain condition would compromise operative knee pain evaluation Inflammatory arthridities ( e.g. , rheumatoid arthritis , lupus , ankylose spondylitis , psoriatic arthritis ) , exception clinically stable/nonactive gout affect knee interfere walk Operative arthroscopy surgical knee last 4 month ( except meniscal repair short 6 month randomization ) contralateral knee last 2 month ( 3 month meniscal repair ) , prior surgery either knee last 12 month , except diagnostic arthroscopy Planned use follow TKA : general anesthesia use potent inhalational agent , peripheral nerve block ( i.e. , femoral nerve block ) , neuroaxial ( intrathecal epidural ) opioids postoperatively , knee capsule injection Received aspirin nonsteroidal antiinflammatory drug ( NSAID ) prior randomization within washout period require surgical team surgery spinal anesthetic , plan use NSAIDS postoperatively Day 28 Use 20 mg per day ( average ) oral morphine equivalent within 1 month prior randomization Use adjuvant analgesic chronic pain control ( e.g. , gabapentin , pregabalin ) within 2 week prior randomization plan use postoperatively Day 28 Daily use benzodiazepine 3 month prior randomization ( unless use sleep dosage consistent surgery ) Use systemic corticosteroid ( include inhale steroid ) within 3 month intraarticular steroid injection within 1 month prior randomization , plan use either postoperatively Day 28 Treatment immunosuppressive , antipsychotic , anticholinergic , anticonvulsant within 1 month randomization , exception aspirin cardiac prophylaxis ( long discontinue within 1 week randomization ) Current neurologic disorder , could confound assessment pain ( e.g. , Parkinson 's , Multiple Sclerosis ) Current active depression symptom Has change dose regimen SSRIs SNRIs depression within 1 month randomization Mini Mental State Exam score &lt; 24 Screening Severe pulmonary disease ; symptomatic sleep apnea currently treat continuous positive airway pressure ( CPAP ) bilevel positive airway pressure ( BIPAP ) , use must continue postoperatively least inpatient period . Patients sleep apnea associate history postoperative delirium exclude . Current evidence alcohol abuse history alcoholrelated complication within 1 year randomization include , limited , alcoholic withdrawal seizure , hallucination , delirium tremens detoxification treatment Known suspect history illicit drug abuse within 1 year randomization , current plan use medical marijuana , history opioid dependence within 2 year randomization Any malignancy within past year , exception basal cell carcinoma uncomplicated stable skin cancer document require immediate treatment Women pregnant nursing Previous participation study involve AYX1 Injection</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Postsurgical pain</keyword>
	<keyword>Total knee arthroplasty</keyword>
	<keyword>Total knee replacement</keyword>
</DOC>